Upstream Bio (UPB) Revenue (2023 - 2026)

Upstream Bio's Revenue history runs 4 years deep, the most recent figure standing at $1.0 million for Q1 2026.

• In Q1 2026, Revenue rose 82.69% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $3.3 million (up 44.69% YoY), while the FY2025 annual figure was $2.9 million, up 20.42% from the prior year.
• Revenue was $1.0 million for Q1 2026 at Upstream Bio, up from $668000.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $1.0 million in Q1 2026 to a low of $450000.0 in Q4 2023.
• Historically, Revenue has averaged $666272.7 across 4 years, with a median of $621000.0 in 2023.
• Biggest YoY gain for Revenue was 83.73% in 2025; the steepest drop was 11.56% in 2025.
• A 4-year view of Revenue shows it stood at $450000.0 in 2023, then soared by 36.22% to $613000.0 in 2024, then grew by 8.97% to $668000.0 in 2025, then jumped by 54.79% to $1.0 million in 2026.
• The last three Revenue figures came in at $1.0 million (Q1 2026), $668000.0 (Q4 2025), and $683000.0 (Q3 2025), per Business Quant data.